ESC 365 - Diabetic ketoacidosis in patients with type 2 diabetes mellitus receiving sodium-glucose co-transporter-2 inhibitors: The Hong Kong Diabetes Study

Open Access

Diabetic ketoacidosis in patients with type 2 diabetes mellitus receiving sodium-glucose co-transporter-2 inhibitors: The Hong Kong Diabetes Study

Session: Effectively managing cardiovascular risk in Type 2 diabetes

Topic: Antidiabetic Pharmacotherapy

Speaker: Professor G. Tse (Hong Kong, CN)

Event: ESC Preventive Cardiology 2024

Congress Presentation

Add to my library

About the speaker

Professor Gary Tse

Hong Kong Metropolitan University, Hong Kong (China)

1 presentation

0 follower

4 more presentations in this session

Quiz presentation

Speaker: Doctor S. Gati (London, GB) Professor V. Vassiliou (Norwich, GB)

Effects of urinary tract infection and stopping sodium-glucose cotranspoter-2 inhibitors in patients with type 2 diabetes mellitus: a population-based study

Speaker: Professor Y. Kai Hang (Shenzhen, CN)

Potentially avoidable hospitalizations for diabetes in Switzerland

Speaker: Doctor K. Maung (Lausanne, CH)

Combined effects of gamma-glutamyltransferase and high-sensitivity C-reactive protein on cardiovascular events in patients with diabetes and chronic coronary syndrome

Speaker: Doctor T. Li (Beijing, CN)

Access the full session

Effectively managing cardiovascular risk in Type 2 diabetes

Speakers: Professor G. Tse, Doctor S. Gati, Professor V. Vassiliou, Professor Y. Kai Hang, Doctor K. Maung...

About the event

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources